Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study

• Ngā kaituhi matua: Qiao Guo (Author), Lei Yang (Author), Ran Peng (Author), Tao Gao (Author), Xinglin Chu (Author), Depeng Jiang (Author), Dazhi Ke (Author), Hong Ren (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background and aimsThe prevalence of metabolic syndrome (MS), wich mainly including hypertension, hyperglycemia, hyperlipidemia, remains high, and the safety and antibody response of inactivated coronavirus disease 2019 (COVID-19) vaccination in patients with metabolic syndrome (MS) is still inconsi...